FDA Issues Warning Letter to Medtronic, Inc.

WASHINGTON - Federal regulators have warned Medtronic Inc. for not promptly reporting problems with some of its medical devices that may have caused serious injury or death. The Food and Drug Administration posted a warning letter to the company on its Web site Tuesday detailing problems at a Minneapolis, Minn. plant that makes drug infusion pumps and neurostimulation devices. Both products are often used to treat chronic pain and neurological disorders.

MORE ON THIS TOPIC